Status:
COMPLETED
Effects of an Oxymizer® During Daytime in Patients With Pulmonary Fibrosis (IPF)
Lead Sponsor:
Schön Klinik Berchtesgadener Land
Conditions:
Idiopathic Pulmonary Fibrosis
Eligibility:
All Genders
30-80 years
Phase:
NA
Brief Summary
This study will investigate the effects of a reservoir nasal cannula (Oxymizer®) compared to a conventional nasal cannula (CNC) in patients with idiopathic pulmonary fibrosis.
Detailed Description
Patients will be recruited during a 3-week inpatient pulmonary rehabilitation program. They will perform the following three interventions on consecutive days and will repeat them after a week. During...
Eligibility Criteria
Inclusion
- IPF patients with indication for long term oxygen therapy ≥ 2l/min
- VC \>30% and \< 70% pred.
Exclusion
- failure to comply with study process
- acute infection
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2015
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT02268981
Start Date
September 1 2014
End Date
September 1 2015
Last Update
September 3 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinikum Berchtesgadener Land der Schön-Kliniken
Schönau am Königssee, Bavaria, Germany, 83471